AUSTIN, Texas--(BUSINESS WIRE)--EverlyWell, the next-generation health testing platform, today announced the launch of three new biomarker and genomics products that will expand its established suite of at-home lab testing kits that provide insights about health and wellness. The new tests, which harness DNA to yield personalized information about food sensitivity, metabolism, and breast milk DHA, were developed in collaboration with Helix, a personal genomics company that today launched the first online marketplace for DNA-based products.
EverlyWell’s new products will be available on the Helix marketplace along with a diverse range of other DNA-based products focused on health, fitness, nutrition, family, ancestry and entertainment.
“We are proud to bring the latest in DNA sequencing technology to our customers through the Helix marketplace. Our selection as a Helix launch partner is further validation of EverlyWell’s platform and the exceptional consumer experience we’ve created,” says Julia Cheek, CEO and Founder, EverlyWell. “By sharing DNA information alongside key nutrition and metabolic biomarkers that we already offer, EverlyWell is now at the forefront of genomic and biomarker consumer testing.”
Today’s partnership with Helix makes EverlyWell one of only a handful of companies in the U.S. offering combined biomarker and genomics testing. The first three products available in the Helix online marketplace include:
- Food Sensitivity+ ($249): Measure sensitivity to foods and the impact DNA may have on the ability to digest certain foods and nutrients.
- Metabolism+ ($149): Check current hormone levels and learn how DNA factors may affect weight through alterations in metabolism.
- Breast Milk DHA+ ($89): Learn how much omega-3 DHA is in a woman’s breast milk and if DNA may affect your levels of DHA.
With Helix, customers will only need to have their DNA sequenced once to utilize the new EverlyWell products. When a new Helix customer purchases an EverlyWell product via the Helix marketplace, they will receive two kits in the mail: one to collect a DNA sample and one to collect their biomarker sample. These kits will be returned in the postage-paid envelopes included with each kit. After returning the samples, biomarker results should be available within 5 days. For new Helix customers, the DNA-based results should be available within 6-8 weeks.
“Helix and EverlyWell have a shared mission to help people live healthier, happier and stronger. Improving access to genomic sequencing will encourage more people to sequence their genome, which in turn will increase the utility of genomic information,” said Robin Thurston, CEO of Helix. “Helix is pleased to be working with EverlyWell who, like us, believes that providing people with access to a wide variety of DNA-based insights accelerates innovation and increases the value of DNA-based products and services.”
EverlyWell provides at-home lab testing kits with easy to understand results. They are the only company offering a suite of physician-reviewed lab tests that can be ordered and collected by consumers without leaving home. Test orders are reviewed and approved by independent board certified physicians. The EverlyWell platform currently offers 13 different at-home lab tests focused on sexual health, thyroid, metabolism, men’s health, and breast milk DHA testing, which the company is the exclusive provider of in the United States.
Led by founder and CEO Julia Cheek, EverlyWell has raised $5 million to date and is one of the fastest-growing consumer healthcare startups in recent history. They’ve reached millions in sales in just one year after launching in beta -- while also delivering profitable unit economics. The company has 17 employees and thousands of customers around the country.
EverlyWell’s products on the Helix marketplace can be accessed at www.Helix.com.
High-resolution images are available to download at www.everlywell.com/media.
Founded in 2015, EverlyWell offers a suite of physician-reviewed at-home lab tests without a lab visit or an in-person doctor referral. Board certified physicians review and approve test orders. The EverlyWell platform empowers consumers to understand their own physician-reviewed lab tests with the goal of improving health and wellness. With the exception of STD testing, EverlyWell’s tests provide personalized information and education to the consumer; they are not intended to diagnose any disease or condition or to substitute for professional medical advice or treatment. EverlyWell is headquartered in Austin, TX. Find out more at EverlyWell.com, and follow us on Facebook or Twitter.
Helix is a personal genomics company with a simple but powerful mission: to empower every person to improve their life through DNA. We’ve created the first marketplace for DNA-powered products where people can explore diverse and uniquely personalized products developed by high-quality partners. Helix handles sample collection, DNA sequencing, and secure data storage so that our partners can integrate DNA insights into products across a range of categories, including ancestry, entertainment, family, fitness, health and nutrition. From profound insights to just-for-fun discoveries, Helix is here to help people live a fuller life. Helix is headquartered in the San Francisco Bay Area, and has a CLIA- and CAP-accredited Next Generation Sequencing lab powered by Illumina (NASDAQ:ILMN) NGS technology, in San Diego. Helix was created in 2015 with founding support from Illumina, its largest shareholder. Learn more at www.helix.com.